Market Cap

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Market Capitalization:

CN¥4.60 Billion

CNY as of Jan. 1, 2024

US$646.5 Million

business Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Company Profile

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Main Stock Listing

SSE: 603168

Market Capitalization History of Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $89.09 B
MERCK Kommanditgesellschaft auf Aktien $67.64 B
Takeda Pharmaceutical Company Limited $47.71 B
Haleon plc $38.90 B
PPD, Inc. $16.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. market cap

Date Market Cap YoY Change
Jan. 1, 2024 CN¥4.60 B 55.56%
Jan. 1, 2023 CN¥2.95 B -13.52%
Jan. 1, 2022 CN¥3.42 B 51.57%
Jan. 1, 2021 CN¥2.25 B -33.15%
Jan. 1, 2020 CN¥3.37 B 44.80%
Jan. 1, 2019 CN¥2.33 B -37.79%
Jan. 1, 2018 CN¥3.74 B -53.79%
Jan. 1, 2017 CN¥8.10 B 6.49%
Jan. 1, 2016 CN¥7.61 B 0.72%
Jan. 1, 2015 CN¥7.55 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +313.24%

$10,000 in May 2023 would now be $41,324 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Categories

China languages Healthcare languages Drug Manufacturers—Specialty & Generic
China Healthcare China Drug Manufacturers—Specialty & Generic

Stocks & Indices

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. has the following listings and related stock indices.


Stock: SSE: 603168

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.